| 0 MONTH PD Tamma, JH Powers | | |
| 1109. A multicenter, observational study to compare the effectiveness of C eftazidime-A vibactam versus C eftolozane-T azobactam for multidrug-resistant Pseudomonas aeruginosa … RK Shields, LM Abbo, R Ackley, SL Aitken, B Albrecht, A Babiker, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 082, 2023 | | 2023 |
| 1202. A Multi-Center Validation of the Electronic Health Record ‘Admission Source’Field Against Clinical Notes for Identifying Hospitalized Patients with Long-term Care … KE Goodman, M Taneja, L Magder, P Resnik, M Sutherland, S Sorongon, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1035, 2022 | | 2022 |
| 14. Outcomes from the AHRQ Safety Program for Improving Antibiotic Use Across 439 Long-term Care Facilities M Katz, TA Rowe, SE Cosgrove, PD Tamma, MA Miller, P Dullabh, ... Open Forum Infectious Diseases 7 (Supplement_1), S8-S8, 2020 | | 2020 |
| 1511. Effect of Discharge Antibiotic Route on Clinical Outcomes in Children with Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis with Bacteremia J Olson, RF Hamdy, AJ Hsu, P Tamma, P Tamma, J Gerber, D Dona, ... Open Forum Infectious Diseases 6 (Supplement_2), S549-S550, 2019 | | 2019 |
| 1588. Clinical Prediction Tool for Extended-Spectrum Β Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients R Wang, E Lautenbach, J Han, E Blumberg, P Tamma, K Thom, K Alby, ... Open Forum Infectious Diseases 5 (suppl_1), S497-S497, 2018 | 2 | 2018 |
| 161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory … SC Keller, TM Caballero, P Tamma, MA Miller, P Dullabh, R Ahn, ... Open forum infectious diseases 8 (Suppl 1), S97, 2021 | 1 | 2021 |
| 1881. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Results From a National Antibiotic Stewardship Intervention of 402 … P Tamma, P Tamma, MA Miller, P Dullabh, R Ahn, K Speck, Y Gao, ... Open Forum Infectious Diseases 6 (Supplement_2), S50-S50, 2019 | | 2019 |
| 195. Duration of Therapy for Streptococcal Bacteremia JM Boulos, V Fabre, K Dzintars, K Dzintars, G Jones, SE Cosgrove, ... Open Forum Infectious Diseases 8 (Supplement_1), S205-S205, 2021 | | 2021 |
| 203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream … SM Karaba, J Hyoung Lee, S Fiawoo, SE Cosgrove, P Tamma Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 276, 2023 | | 2023 |
| 215. Shorter vs. Longer Duration of Treatment in Patients with Ceftriaxone-resistant and Ceftriaxone-susceptible Escherichia coli Bloodstream Infections NA Mackow, L Ge, L Komarow, W Shao, E Herc, Y Doi, CA Arias, O Albin, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 288, 2023 | | 2023 |
| 2165. Assessing the Impact of Meropenem Exposure on Ceftolozane/tazobactam-resistance Development in Pseudomonas aeruginosa using in vitro Serial Passage A Fouad, S Nicolau, P Tamma, PJ Simner, DP Nicolau, CM Gill Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1788, 2023 | | 2023 |
| 2253. Comparison of Outcomes Between Patients with and without Cystic Fibrosis Treated with Ceftolozane–Tazobactam for Pseudomonas aeruginosa Infections MJ Trisler, P Tamma, E Avdic Open Forum Infectious Diseases 6 (Suppl 2), S771, 2019 | | 2019 |
| 2310. Reasons Pediatric Providers Obtain Endotracheal Aspirate Cultures and How Results Inform Patient Management A Sick-Samuels, J Fackler, P Tamma, AM Milstone Open Forum Infectious Diseases 5 (Suppl 1), S686, 2018 | | 2018 |
| 2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients? H Stambaugh, S Lewis, EB Jacobs, DA Hareza, Y Bergman, SE Cosgrove, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2105, 2023 | | 2023 |
| 2770. Investigating the Impact of Non-CTX-M Producing ESBL-E Bloodstream Infections on Patient Outcomes DA Hareza, PJ Simner, S Fiawoo, JH Lee, Y Bergman, EB Jacobs, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2381, 2023 | | 2023 |
| 279. A Decision Tree Using Clinical Characteristics to Predict a Hospitalized Child’s Risk of a Multidrug-Resistant Gram-Negative Bloodstream Infection A Sick-Samuels, K Goodman, G Rapsinski, E Colantuoni, A Nowalk, ... Open Forum Infectious Diseases 5 (Suppl 1), S115, 2018 | | 2018 |
| 371 Outcomes of Enterobacter bloodstream infection in hospitalized children B Larru, N Vendetti, PD Tamma, R Bannerjee, T Madigan, R Localio, ... Open Forum Infectious Diseases 1 (suppl_1), S145-S145, 2014 | | 2014 |
| 38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population SM Karaba, J Amoah, SE Cosgrove, PD Tamma Open Forum Infectious Diseases 7 (Suppl 1), S20, 2020 | | 2020 |
| 52. Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia EY Bae, F Bernice, K Dzintars, SE Cosgrove, PD Tamma, E Avdic Open Forum Infectious Diseases 7 (Supplement_1), S48-S48, 2020 | 1 | 2020 |
